Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parasympathetic Activity in Asthma with Fixed Airway Obstruction
NCT05550402Recruiting
- Sponsor
- Hat Yai Hospital Medical Education Center
- Start
- Feb 2024
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-blind trial of ipratropium bromide in asthma (4 arms), sponsored by Hat Yai Hospital Medical Education Center. Primary endpoint: Average Forced Expiratory Volume in 1 second at 6 hours. Started Feb 2024; status: recruiting.
02
Drugs
ipratropium bromide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT05550402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05550402.